Accelerate Diagnostics, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AXDX research report →
Companyacceleratediagnostics.com
Accelerate Diagnostics, Inc. , an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms.
- CEO
- Jack Phillips
- IPO
- 1994
- Employees
- 107
- HQ
- Tucson, AZ, US
Price Chart
Valuation
- Market Cap
- $859.92K
- P/E
- -0.02
- P/S
- 0.07
- P/B
- -0.01
- EV/EBITDA
- -1.56
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 23.12%
- Op Margin
- -301.85%
- Net Margin
- -427.81%
- ROE
- 131.82%
- ROIC
- -243.30%
Growth & Income
- Revenue
- $11.70M · -2.99%
- Net Income
- $-50,045,000 · 18.78%
- EPS
- $-2.15 · 56.48%
- Op Income
- $-35,310,000
- FCF YoY
- 40.09%
Performance & Tape
- 52W High
- $2.09
- 52W Low
- $0.01
- 50D MA
- $0.60
- 200D MA
- $1.28
- Beta
- 0.22
- Avg Volume
- 1.86M
Get TickerSpark's AI analysis on AXDX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 10, 25 | NATHAN GILBERT E | other | 0 |
| Apr 10, 25 | Shalhoub Paul Vincent | other | 0 |
| Apr 4, 25 | Phillips Jack | other | 53,283 |
| Apr 4, 25 | Phillips Jack | sell | 25,343 |
| Apr 4, 25 | Phillips Jack | other | 53,283 |
| Apr 4, 25 | Mertz Larry Michael | other | 4,298 |
| Apr 4, 25 | Mertz Larry Michael | sell | 1,523 |
| Apr 4, 25 | Mertz Larry Michael | other | 4,298 |
| Apr 1, 25 | Patience David | other | 20,000 |
| Apr 1, 25 | Patience David | sell | 6,816 |
Our AXDX Coverage
We haven't published any research on AXDX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate AXDX Report →